Common use of Company Designated Representations Clause in Contracts

Company Designated Representations. “Company Designated Representations” shall mean the representations and warranties set forth in Sections 2.1, 2.22, 2.24 and 2.27. Company Disclosure Schedule. “Company Disclosure Schedule” shall mean the Company Disclosure Schedule that has been prepared by the Company in accordance with the requirements of Section 9.6 of the Agreement and that has been delivered by the Company to Parent on the date of the Agreement.

Appears in 4 contracts

Samples: Agreement and Plan of Merger (La Jolla Pharmaceutical Co), Agreement and Plan of Merger (Tetraphase Pharmaceuticals Inc), Agreement and Plan of Merger (Tetraphase Pharmaceuticals Inc)

AutoNDA by SimpleDocs

Company Designated Representations. “Company Designated Representations” shall mean the representations and warranties set forth in Sections 2.1, 2.22, 2.24 and 2.27. Company Disclosure Schedule. “Company Disclosure Schedule” shall mean the Company Disclosure Schedule that has been prepared by the Company in accordance with the requirements of Section 9.6 8.6 of the this Agreement and that has been delivered by the Company to Parent on the date of the this Agreement.

Appears in 3 contracts

Samples: Agreement and Plan of Merger (La Jolla Pharmaceutical Co), Agreement and Plan of Merger (Innoviva, Inc.), Agreement and Plan of Merger (La Jolla Pharmaceutical Co)

Company Designated Representations. “Company Designated Representations” shall mean the representations and warranties set forth in Sections 2.12.3(a), 2.222.3(c), 2.24 2.3(e), 2.20, 2.21, 2.22 and 2.272.24. Company Disclosure Schedule. “Company Disclosure Schedule” shall mean the Company Disclosure Schedule that has been prepared by the Company in accordance with the requirements of Section 9.6 of the Agreement and that has been delivered by the Company to Parent on the date of the Agreement.

Appears in 2 contracts

Samples: Agreement and Plan of Merger and Reorganization (TEKMIRA PHARMACEUTICALS Corp), Agreement and Plan of Merger and Reorganization (TEKMIRA PHARMACEUTICALS Corp)

Company Designated Representations. “Company Designated Representations” shall mean the representations and warranties set forth in Sections 2.12.3(a) (the first sentence only), 2.3(d)(i), 2.3(d)(iv), 2.3(g), 2.21, 2.22, 2.24 2.23, 2.25, 2.26 and 2.27. Company Disclosure Schedule. “Company Disclosure Schedule” shall mean the Company Disclosure Schedule that has been prepared by the Company in accordance with the requirements of Section 9.6 of the Agreement and that has been delivered by the Company to Parent on the date of the Agreement.

Appears in 2 contracts

Samples: Agreement and Plan of Merger and Reorganization (Bookham, Inc.), Agreement and Plan of Merger and Reorganization (Avanex Corp)

Company Designated Representations. “Company Designated Representations” shall mean the representations and warranties set forth in Sections 2.12.3(a) (the first sentence only), 2.3(d), 2.3(f), 2.21, 2.22, 2.24 2.23, 2.25, 2.26 and 2.27. Company Disclosure Schedule. “Company Disclosure Schedule” shall mean the Company Disclosure Schedule that has been prepared by the Company in accordance with the requirements of Section 9.6 of the Agreement and that has been delivered by the Company to Parent on the date of the Agreement.

Appears in 2 contracts

Samples: Agreement and Plan of Merger and Reorganization (Opnext Inc), Agreement and Plan of Merger and Reorganization (Oclaro, Inc.)

Company Designated Representations. “Company Designated Representations” shall mean the representations and warranties set forth in Sections 2.13.3(a), 2.223.3(c), 2.24 3.3(f), 3.21, 3.22, 3.23, 3.26 and 2.273.28. Company Disclosure Schedule. “Company Disclosure Schedule” shall mean the Company Disclosure Schedule that has been prepared by the Company in accordance with the requirements of Section 9.6 of the Agreement and that has been delivered by the Company to Parent on the date of the Agreement.

Appears in 2 contracts

Samples: Agreement and Plan of Merger (Allos Therapeutics Inc), Agreement and Plan of Merger (Spectrum Pharmaceuticals Inc)

Company Designated Representations. “Company Designated Representations” shall mean the representations and warranties set forth in Sections 2.12.1(a), 2.1(b), 2.22, 2.24 2.24, 2.25(a) and 2.27. Company Disclosure Schedule. “Company Disclosure Schedule” shall mean the Company Disclosure Schedule that has been prepared by the Company in accordance with the requirements of Section 9.6 8.6 of the Agreement and that has been delivered by the Company to Parent on the date of the Agreement.

Appears in 2 contracts

Samples: Agreement and Plan of Merger (AutoWeb, Inc.), Agreement and Plan of Merger (AutoWeb, Inc.)

AutoNDA by SimpleDocs

Company Designated Representations. “Company Designated Representations” shall mean the representations and warranties set forth in Sections 2.1Section 2.3(a), 2.22Section 2.3(b), 2.24 Section 2.3(c), Section 2.3(d), Section 2.5(a), Section 2,19, and 2.27Section 2.25. Company Disclosure Schedule. “Company Disclosure Schedule” shall mean the Company Disclosure Schedule that has been prepared by the Company in accordance with the requirements of Section 9.6 8.6 of the Agreement and that has been delivered by the Company to Parent on the date of the Agreement.

Appears in 2 contracts

Samples: Agreement and Plan of Merger (Gulfmark Offshore Inc), Agreement and Plan of Merger (Tidewater Inc)

Company Designated Representations. “Company Designated Representations” shall mean the representations and warranties set forth in Sections 2.12.3(a), 2.3(c), 2.3(e), 2.21, 2.22, 2.24 2.23 and 2.272.26. Company Disclosure Schedule. “Company Disclosure Schedule” shall mean the Company Disclosure Schedule that has been prepared by the Company in accordance with the requirements of Section 9.6 of the Agreement and that has been delivered by the Company to Parent on the date of the Agreement.

Appears in 2 contracts

Samples: Agreement and Plan of Merger and Reorganization (Accelrys, Inc.), Agreement and Plan of Merger and Reorganization (Accelrys, Inc.)

Company Designated Representations. “Company Designated Representations” shall mean the representations and warranties set forth in Sections 2.1, 2.222.23, 2.24 2.24, 2.25, 2.26 and 2.272.28. Company Disclosure Schedule. “Company Disclosure Schedule” shall mean the Company Disclosure Schedule that has been prepared by the Company in accordance with the requirements of Section 9.6 8.6 of the Agreement and that has been delivered by the Company to Parent on the date of the Agreement.

Appears in 1 contract

Samples: Agreement and Plan of Merger (Applied Genetic Technologies Corp)

Time is Money Join Law Insider Premium to draft better contracts faster.